Skip to main content
Premium Trial:

Request an Annual Quote

G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa

NEW YORK – G42 Healthcare said on Monday that is has signed a memorandum of understanding with Seegene of South Korea to offer fully equipped mobile diagnostics laboratories across the Middle East and North Africa region.

Financial and other terms were not disclosed.

Under the partnership, the firms will offer the Seegene Mobile Station, a laboratory-on-wheels facility for molecular diagnostic testing that includes equipment, RT-PCR reagents, consumables, IT solutions, and technical support. The lab can be transported by ship or land, and be made operational within a few days. It enables users to conduct up to 2,000 tests per day, including for 225 pathogens.

"We are proud to enter into a collaboration with Seegene which offers equitable access to healthcare anywhere in the Pan-Arab region. This is part of our joint efforts with international organizations to share our knowledge and expertise to future-proof the health of nations," said G42 Healthcare CEO Ashish Koshy in a statement.

"With this collaboration, we will join forces to serve the local communities with our expertise and resources. The Seegene Mobile Station will offer the most innovative mobile molecular diagnostic, testing and laboratory services and is part of our commitment to supporting the healthcare community in combating COVID-19 infections, with a broad portfolio of research and development tools and diagnostics," added James Park, Seegene's executive director.

G42 Healthcare, based in Abu Dhabi, is a health tech company that aims to develop the healthcare sector in the United Arab Emirates and beyond using artificial intelligence, scientific research, and technology in genomics, digital health, diagnostics, and clinical trials.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.